• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SOS1 酪氨酸 1196 的磷酸化促进其 RAC GEF 活性,并有助于 BCR-ABL 白血病的发生。

Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis.

机构信息

Department of Molecular Oncology, IFOM Foundation, Institute FIRC of Molecular Oncology, Milan, Italy.

Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca) and CIBERONC, Salamanca, Spain.

出版信息

Leukemia. 2018 Mar;32(3):820-827. doi: 10.1038/leu.2017.267. Epub 2017 Aug 18.

DOI:10.1038/leu.2017.267
PMID:28819285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5739283/
Abstract

Son of Sevenless 1 (SOS1) is a dual guanine nucleotide exchange factor (GEF) that activates the small GTPases RAC and RAS. Although the molecular mechanisms of RAS GEF catalysis have been unveiled, how SOS1 acquires RAC GEF activity and what is the physio-pathological relevance of this activity is much less understood. Here we show that SOS1 is tyrosine phosphorylated on Y1196 by ABL. Phosphorylation of Y1196 controls SOS1 inter-molecular interaction, is required to promote the exchange of nucleotides on RAC in vitro and for platelet-derived growth factor (PDGF) activation of RAC- and RAC-dependent actin remodeling and cell migration. SOS1 is also phosphorylated on Y1196 by BCR-ABL in chronic myelogenous leukemic cells. Importantly, in these cells, SOS1 is required for BCR-ABL-mediated activation of RAC, cell proliferation and transformation in vitro and in a xenograft mouse model. Finally, genetic removal of Sos1 in the bone marrow-derived cells (BMDCs) from Sos1 mice and infected with BCR-ABL causes a significant delay in the onset of leukemogenesis once BMDCs are injected into recipient, lethally irradiated mice. Thus, SOS1 is required for full transformation and critically contribute to the leukemogenic potential of BCR-ABL.

摘要

七遍体 1 之子(SOS1)是一种双鸟嘌呤核苷酸交换因子(GEF),能激活小分子 GTP 酶 RAC 和 RAS。尽管 RAS GEF 催化的分子机制已经被揭示,但 SOS1 如何获得 RAC GEF 活性以及这种活性的生理病理相关性还知之甚少。在这里,我们表明 SOS1 可被 ABL 在 Y1196 上发生酪氨酸磷酸化。Y1196 的磷酸化控制 SOS1 分子间相互作用,是体外促进 RAC 上核苷酸交换以及血小板衍生生长因子(PDGF)激活 RAC 和 RAC 依赖性肌动蛋白重构和细胞迁移所必需的。BCR-ABL 还可在慢性髓性白血病细胞中使 SOS1 在 Y1196 上磷酸化。重要的是,在这些细胞中,SOS1 是 BCR-ABL 介导的 RAC 激活、体外细胞增殖和转化以及异种移植小鼠模型所必需的。最后,从 Sos1 敲除小鼠的骨髓来源细胞(BMDC)中遗传去除 Sos1 并感染 BCR-ABL,一旦将 BMDC 注入受照射致死的受体小鼠中,就会导致白血病发生的明显延迟。因此,SOS1 是完全转化所必需的,并对 BCR-ABL 的白血病发生潜能有重要贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f656/5843899/1a32d8c84df1/leu2017267f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f656/5843899/102aee479a18/leu2017267f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f656/5843899/4c896b37e618/leu2017267f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f656/5843899/7b06251d281b/leu2017267f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f656/5843899/a123a04a0ff4/leu2017267f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f656/5843899/1a32d8c84df1/leu2017267f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f656/5843899/102aee479a18/leu2017267f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f656/5843899/4c896b37e618/leu2017267f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f656/5843899/7b06251d281b/leu2017267f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f656/5843899/a123a04a0ff4/leu2017267f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f656/5843899/1a32d8c84df1/leu2017267f5.jpg

相似文献

1
Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis.SOS1 酪氨酸 1196 的磷酸化促进其 RAC GEF 活性,并有助于 BCR-ABL 白血病的发生。
Leukemia. 2018 Mar;32(3):820-827. doi: 10.1038/leu.2017.267. Epub 2017 Aug 18.
2
Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia.SOS1的靶向降解展现出强大的抗癌活性,并克服了KRAS突变肿瘤和BCR-ABL阳性白血病中的耐药性。
Cancer Res. 2025 Jan 2;85(1):101-117. doi: 10.1158/0008-5472.CAN-24-1093.
3
Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway.Bcr-Abl与原癌基因Vav的关联涉及Rac-1信号通路的激活。
J Biol Chem. 2002 Apr 5;277(14):12437-45. doi: 10.1074/jbc.M112397200. Epub 2002 Jan 14.
4
Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation.Sos-1的Abl依赖性酪氨酸磷酸化介导生长因子诱导的Rac激活。
Nat Cell Biol. 2004 Mar;6(3):268-74. doi: 10.1038/ncb1096. Epub 2004 Feb 22.
5
Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells.p21 RAS在鼠类髓系细胞p210 bcr-abl转化中的作用。
Blood. 1993 Sep 15;82(6):1838-47.
6
CIIA functions as a molecular switch for the Rac1-specific GEF activity of SOS1.CIIA 作为 SOS1 特异性 Rac1 GEF 活性的分子开关发挥作用。
J Cell Biol. 2011 Oct 31;195(3):377-86. doi: 10.1083/jcb.201106138.
7
Vav3 collaborates with p190-BCR-ABL in lymphoid progenitor leukemogenesis, proliferation, and survival.Vav3 与 p190-BCR-ABL 在淋巴祖细胞白血病发生、增殖和存活中协同作用。
Blood. 2012 Jul 26;120(4):800-11. doi: 10.1182/blood-2011-06-361709. Epub 2012 Jun 12.
8
Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia.SOS1对BCR/ABL驱动的慢性粒细胞白血病发展的关键需求。
Cancers (Basel). 2022 Aug 11;14(16):3893. doi: 10.3390/cancers14163893.
9
BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac.BCR/ABL介导的白血病发生需要小GTP结合蛋白Rac的活性。
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11858-62. doi: 10.1073/pnas.95.20.11858.
10
Sos1 Regulates Macrophage Podosome Assembly and Macrophage Invasive Capacity.Sos1调节巨噬细胞足体组装及巨噬细胞侵袭能力。
J Immunol. 2015 Nov 15;195(10):4900-12. doi: 10.4049/jimmunol.1500579. Epub 2015 Oct 7.

引用本文的文献

1
SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRAS inhibitor in KRAS LUAD.SOS1抑制剂BI-3406在体内显示出与基因消融相似的抗肿瘤活性,并在KRAS驱动的肺腺癌中与KRAS抑制剂协同作用。
Proc Natl Acad Sci U S A. 2025 Mar 18;122(11):e2422943122. doi: 10.1073/pnas.2422943122. Epub 2025 Mar 12.
2
Sos1 ablation alters focal adhesion dynamics and increases Mmp2/9-dependent gelatinase activity in primary mouse embryonic fibroblasts.Sos1基因敲除改变了原代小鼠胚胎成纤维细胞中的粘着斑动力学,并增加了Mmp2/9依赖性明胶酶活性。
Cell Commun Signal. 2025 Mar 3;23(1):116. doi: 10.1186/s12964-025-02122-1.
3

本文引用的文献

1
Vav family exchange factors: an integrated regulatory and functional view.Vav家族交换因子:综合调控与功能视角
Small GTPases. 2014;5(2):9. doi: 10.4161/21541248.2014.973757.
2
DRK/DOS/SOS converge with Crk/Mbc/dCed-12 to activate Rac1 during glial engulfment of axonal debris.在轴突碎片的神经胶质吞噬过程中,DRK/DOS/SOS与Crk/Mbc/dCed - 12汇聚以激活Rac1。
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12544-9. doi: 10.1073/pnas.1403450111. Epub 2014 Aug 6.
3
An orthosteric inhibitor of the RAS-SOS interaction.一种RAS-SOS相互作用的正构抑制剂。
Discovery of Small Molecules that Bind to Son of Sevenless 2 (SOS2).
与七号无翅基因之子2(SOS2)结合的小分子的发现
J Med Chem. 2025 Feb 13;68(3):2680-2693. doi: 10.1021/acs.jmedchem.4c02007. Epub 2025 Jan 17.
4
Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia.SOS1的靶向降解展现出强大的抗癌活性,并克服了KRAS突变肿瘤和BCR-ABL阳性白血病中的耐药性。
Cancer Res. 2025 Jan 2;85(1):101-117. doi: 10.1158/0008-5472.CAN-24-1093.
5
SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma.SOS2 调节 EGFR 信号的阈值以调节肺腺癌奥希替尼的疗效和耐药性。
Mol Oncol. 2024 Mar;18(3):641-661. doi: 10.1002/1878-0261.13564. Epub 2024 Jan 18.
6
Critical requirement of SOS1 for tumor development and microenvironment modulation in KRAS-driven lung adenocarcinoma.SOS1 对于 KRAS 驱动的肺腺癌肿瘤发生和微环境调节的关键要求。
Nat Commun. 2023 Sep 20;14(1):5856. doi: 10.1038/s41467-023-41583-1.
7
Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer.治疗非小细胞肺癌中罕见 ALK 融合的新进展。
Curr Oncol. 2022 Oct 16;29(10):7816-7831. doi: 10.3390/curroncol29100618.
8
Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia.SOS1对BCR/ABL驱动的慢性粒细胞白血病发展的关键需求。
Cancers (Basel). 2022 Aug 11;14(16):3893. doi: 10.3390/cancers14163893.
9
NIPA (Nuclear Interaction Partner of ALK) Is Crucial for Effective NPM-ALK Mediated Lymphomagenesis.NIPA(间变性淋巴瘤激酶的核相互作用伙伴)对有效介导NPM-ALK的淋巴瘤发生至关重要。
Front Oncol. 2022 May 13;12:875117. doi: 10.3389/fonc.2022.875117. eCollection 2022.
10
8-Hydroxydaidzein Downregulates JAK/STAT, MMP, Oxidative Phosphorylation, and PI3K/AKT Pathways in K562 Cells.8-羟基大豆苷元下调K562细胞中的JAK/STAT、MMP、氧化磷酸化和PI3K/AKT信号通路。
Biomedicines. 2021 Dec 14;9(12):1907. doi: 10.3390/biomedicines9121907.
Enzymes. 2013;34 Pt. B:25-39. doi: 10.1016/B978-0-12-420146-0.00002-0. Epub 2013 Nov 7.
4
Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival.Sos1 和 Sos2 在淋巴造血和机体稳态及存活中的功能冗余性。
Mol Cell Biol. 2013 Nov;33(22):4562-78. doi: 10.1128/MCB.01026-13. Epub 2013 Sep 16.
5
Functions and regulation of circular dorsal ruffles.环形背鳍皱襞的功能与调控。
Mol Cell Biol. 2012 Nov;32(21):4246-57. doi: 10.1128/MCB.00551-12. Epub 2012 Aug 27.
6
Vav3 collaborates with p190-BCR-ABL in lymphoid progenitor leukemogenesis, proliferation, and survival.Vav3 与 p190-BCR-ABL 在淋巴祖细胞白血病发生、增殖和存活中协同作用。
Blood. 2012 Jul 26;120(4):800-11. doi: 10.1182/blood-2011-06-361709. Epub 2012 Jun 12.
7
CIIA functions as a molecular switch for the Rac1-specific GEF activity of SOS1.CIIA 作为 SOS1 特异性 Rac1 GEF 活性的分子开关发挥作用。
J Cell Biol. 2011 Oct 31;195(3):377-86. doi: 10.1083/jcb.201106138.
8
Life at the leading edge.生命的前沿。
Cell. 2011 Jun 24;145(7):1012-22. doi: 10.1016/j.cell.2011.06.010.
9
Rac GTPases in human diseases.人类疾病中的 Rac GTPases。
Dis Markers. 2010;29(3-4):177-87. doi: 10.3233/DMA-2010-0738.
10
Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo.Rac2 GTPase 缺陷在体内耗尽 BCR-ABL+白血病干细胞和祖细胞。
Blood. 2010 Jul 8;116(1):81-4. doi: 10.1182/blood-2009-10-247437. Epub 2010 Apr 20.